SC
Squadron Capital Management LLC
OAK BROOK IL · SEC CIK 0002050709
$322.25M2026Q2 reported value
43Positions
66.2%Top 10 weight · largest 15.8%
21 / 17New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
CCCC Added+$23.12M
ELVN New+$8.12M
IVA Added+$7.18M
RLAY Added+$5.57M
ADAGENE INC New+$5.25M
2026Q2 top sells estimated at quarter-end value
KALVISTA PHARMAC Sold out-$19.83M
ABVX Sold out-$14.48M
NKTR Sold out-$8.99M
RLMD Reduced-$7.78M
ANL Reduced-$5.75M
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| RLMD | RELMADA THERAPEUTICS INC | $50.86M | 15.78% | 7,350,000 | -1,124,571 | -13.3% | -$7.78M | Reduced |
| CCCC | C4 THERAPEUTICS INC | $33.62M | 10.43% | 7,200,000 | 4,950,000 | 220.0% | $23.12M | Added |
| COGT | COGENT BIOSCIENCES INC | $33.48M | 10.39% | 865,000 | 77,508 | 9.8% | $3.00M | Added |
| KOD | KODIAK SCIENCES INC | $19.48M | 6.05% | 500,000 | 120,000 | 31.6% | $4.68M | Added |
| RLAY | RELAY THERAPEUTICS INC | $18.15M | 5.63% | 970,000 | 297,500 | 44.2% | $5.57M | Added |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $17.95M | 5.57% | 3,700,000 | 69,000 | 1.9% | $334,650 | Added |
| EWTX | EDGEWISE THERAPEUTICS INC | $11.78M | 3.66% | 290,000 | -60,000 | -17.1% | -$2.44M | Reduced |
| MAZE | MAZE THERAPEUTICS INC | $10.00M | 3.10% | 335,000 | 77,500 | 30.1% | $2.31M | Added |
| IVA | INVENTIVA SA | $9.20M | 2.86% | 2,435,000 | 1,900,000 | 355.1% | $7.18M | Added |
| ANL | ADLAI NORTYE LTD | $8.80M | 2.73% | 764,876 | -500,355 | -39.5% | -$5.75M | Reduced |
| ELVN | ENLIVEN THERAPEUTICS INC | $8.12M | 2.52% | 160,000 | 160,000 | — | $8.12M | New |
| AVBP | ARRIVENT BIOPHARMA INC Call | $6.36M | 1.97% | 183,000 | 73,000 | 66.4% | $2.54M | Added |
| PALI | PALISADE BIO INC | $6.27M | 1.95% | 3,000,000 | 0 | 0.0% | — | Unchanged |
| BIOA | BIOAGE LABS INC Call | $6.13M | 1.90% | 250,000 | 250,000 | — | $6.13M | New |
| IKT | INHIBIKASE THERAPEUTICS INC | $6.09M | 1.89% | 3,000,000 | -500,000 | -14.3% | -$1.01M | Reduced |
| — | ADAGENE INC | $5.25M | 1.63% | 1,250,000 | 1,250,000 | — | $5.25M | New |
| — | FORTE BIOSCIENCES INC | $4.78M | 1.48% | 225,000 | 225,000 | — | $4.78M | New |
| RZLT | REZOLUTE INC Call | $4.68M | 1.45% | 900,000 | 900,000 | — | $4.68M | New |
| IFRX | INFLARX NV | $4.48M | 1.39% | 2,000,000 | 2,000,000 | — | $4.48M | New |
| ASMB | ASSEMBLY BIOSCIENCES INC | $4.40M | 1.36% | 160,000 | 160,000 | — | $4.40M | New |
| CMPS | COMPASS PATHWAYS PLC Call | $4.32M | 1.34% | 305,000 | 305,000 | — | $4.32M | New |
| — | PROMIS NEUROSCIENCES INC | $4.28M | 1.33% | 324,977 | 0 | 0.0% | — | Unchanged |
| CTNM | CONTINEUM THERAPEUTICS INC | $4.26M | 1.32% | 260,000 | 260,000 | — | $4.26M | New |
| CMPS | COMPASS PATHWAYS PLC | $4.25M | 1.32% | 300,000 | -88,287 | -22.7% | -$1.25M | Reappeared |
| DFTX | DEFINIUM THERAPEUTICS INC | $4.00M | 1.24% | 85,000 | 85,000 | — | $4.00M | New |
| — | SOL-GEL TECHNOLOGIES LTD | $3.86M | 1.20% | 52,000 | 21,000 | 67.7% | $1.56M | Added |
| BIOA | BIOAGE LABS INC | $3.80M | 1.18% | 155,000 | 155,000 | — | $3.80M | New |
| — | SCYNEXIS INC | $3.08M | 0.96% | 756,884 | -194,203 | -20.4% | -$790,406 | Reduced |
| — | PROQR THRAPEUTICS N V | $2.81M | 0.87% | 1,511,496 | 1,511,496 | — | $2.81M | New |
| IRON | DISC MEDICINE INC Call | $2.19M | 0.68% | 30,000 | 30,000 | — | $2.19M | New |
| RZLT | REZOLUTE INC | $2.10M | 0.65% | 403,410 | 403,410 | — | $2.10M | New |
| — | LIPOCINE INC NEW | $2.07M | 0.64% | 810,000 | 360,000 | 80.0% | $921,600 | Added |
| ZNTL | ZENTALIS PHARMACEUTICALS INC Call | $2.07M | 0.64% | 426,000 | 26,000 | 6.5% | $126,100 | Added |
| CCCC | C4 THERAPEUTICS INC Call | $1.87M | 0.58% | 400,000 | 400,000 | — | $1.87M | New |
| RARE | ULTRAGENYX PHARMACEUTICAL IN Call | $1.84M | 0.57% | 55,000 | 55,000 | — | $1.84M | New |
| — | CUE BIOPHARMA INC | $1.58M | 0.49% | 50,000 | 50,000 | — | $1.58M | New |
| — | CALCIMEDICA INC | $1.28M | 0.40% | 1,244,864 | 1,244,864 | — | $1.28M | New |
| — | QUINCE THERAPEUTICS INC | $734,421 | 0.23% | 40,375 | 40,375 | — | — | First reported |
| NVCT | NUVECTIS PHARMA INC Call | $711,693 | 0.22% | 38,700 | 38,700 | — | $711,693 | New |
| — | PASITHEA THERAPEUTICS CORP | $515,400 | 0.16% | 1,000,000 | -2,150,000 | -68.3% | -$1.11M | Reduced |
| — | INMED PHARMACEUTICALS INC | $503,750 | 0.16% | 325,000 | 325,000 | — | $503,750 | New |
| NMRA | NEUMORA THERAPEUTICS INC. | $170,000 | 0.05% | 100,000 | 100,000 | — | $170,000 | New |
| — | NEXTCURE INC | $103,142 | 0.03% | 64,464 | -200,536 | -75.7% | -$320,856 | Reduced |
| — | KALVISTA PHARMACEUTICALS INC | $0 | 0.00% | 0 | -985,100 | -100.0% | -$19.83M | Sold out |
| ABVX | ABIVAX SA | $0 | 0.00% | 0 | -130,000 | -100.0% | -$14.48M | Sold out |
| NKTR | NEKTAR THERAPEUTICS | $0 | 0.00% | 0 | -125,000 | -100.0% | -$8.99M | Sold out |
| — | KALVISTA PHARMACEUTICALS INC Call | $0 | 0.00% | 0 | -315,000 | -100.0% | -$6.34M | Sold out |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | $0 | 0.00% | 0 | -680,000 | -100.0% | -$4.92M | Sold out |
| GHRS | GH RESEARCH PLC | $0 | 0.00% | 0 | -325,000 | -100.0% | -$4.57M | Sold out |
| KPTI | KARYOPHARM THERAPEUTICS INC Put | $0 | 0.00% | 0 | -750,000 | -100.0% | -$4.18M | Sold out |
| IDYA | IDEAYA BIOSCIENCES INC Put | $0 | 0.00% | 0 | -120,000 | -100.0% | -$4.00M | Sold out |
| IDYA | IDEAYA BIOSCIENCES INC Call | $0 | 0.00% | 0 | -104,300 | -100.0% | -$3.48M | Sold out |
| ALXO | ALX ONCOLOGY HLDGS INC | $0 | 0.00% | 0 | -1,460,000 | -100.0% | -$2.93M | Sold out |
| — | CONTEXT THERAPEUTICS INC | $0 | 0.00% | 0 | -1,100,000 | -100.0% | -$2.88M | Sold out |
| RLAY | RELAY THERAPEUTICS INC Call | $0 | 0.00% | 0 | -150,000 | -100.0% | -$1.49M | Sold out |
| — | TRAWS PHARMA INC | $0 | 0.00% | 0 | -511,714 | -100.0% | -$936,437 | Sold out |
| — | THERAPEUTICSMD INC | $0 | 0.00% | 0 | -420,421 | -100.0% | -$849,250 | Sold out |
| — | SPRUCE BIOSCIENCES INC | $0 | 0.00% | 0 | -12,200 | -100.0% | -$797,270 | Sold out |
| — | WEREWOLF THERAPEUTICS INC | $0 | 0.00% | 0 | -563,535 | -100.0% | -$469,199 | Sold out |
| — | NEUPHORIA THERAPEUTICS INC | $0 | 0.00% | 0 | -76,728 | -100.0% | -$312,283 | Sold out |